Diabetes Health Center

This article is from the WebMD News Archive

Font Size
A
A
A

Inhaled Insulin Gets FDA OK

Exubera Will Provide Alternative to Insulin Injections for Diabetes Patients
By Daniel J. DeNoon
WebMD Health News
Reviewed by Louise Chang, MD

Editor's Note: In October 2007 the drug company Pfizer said it was halting sales of Exubera because of financial reasons.

Jan. 27, 2006 -- Exubera today became the first inhaled insulin to get FDA approval.

It will be on pharmacy shelves by the middle of the year, says Rebecca Hamm, spokeswoman for Exubera maker Pfizer.

Exubera delivers short-acting insulin via an inhaler. It offers adults with type 1 or type 2 diabetes an alternative to the insulin injections they need to control their blood sugar. The device is not approved for use by children younger than 18.

The FDA approval requires the manufacturer to distribute medication guides along with Exubera. The guide contains FDA-approved information written especially for patients.

Exubera is not to be used by smokers or people who have quit smoking within the previous six months. It's also not recommended for people with asthma, bronchitis, or emphysema. However, people with colds or flu should still be able to take the drug, although it may cause coughing.

The FDA recommends that patients get tested for good lung function before beginning Exubera treatment. These tests should be repeated six months and 12 months after starting treatment, and every 12 months thereafter.

The device has been in development for 10 years in a joint effort by Pfizer, Sanofi-Aventis, and Nektar Therapeutics. Earlier this month Pfizer bought Sanofi-Aventis' rights to Exubera. Pfizer and Sanofi-Aventis are WebMD sponsors.

"Until today, patients with diabetes who need insulin to manage their disease had only one way to treat their condition," Steven Galson, MD, director of the FDA's Center for Drug Evaluation and Research, says in a news release. "It is our hope that the availability of inhaled insulin will offer patients more options to better control their blood sugars."

The Exubera device isn't as small as an asthma inhaler. Folded up, it's the size of a standard flashlight. A retractable inhaler tube comes out from the body of the device; when extended it reaches from the chest to the mouth. A blister pack of insulin then must be inserted before the device is triggered. Patients and doctors will get extensive training on how to use Exubera.

Why Inhaled Insulin?

Insulin is made by a small organ called the pancreas. Insulin is an essential hormone that regulates how the body uses sugar, the fuel that feeds every cell in the body. People with diabetes can't make enough insulin to keep their blood sugar under control.

The discovery that insulin could be given to people with diabetes was one of the great medical breakthroughs of all time. Long-acting forms of insulin keep blood sugar under control throughout the day. However, many people with diabetes need more insulin with meals to cope with the spike in blood sugar caused by eating. They also need this insulin to wear off quickly so they don't have a blood-sugar crash when the meal is over.

diabetes newsletter

Health information tailored to the needs of those living with diabetes. Sign up today to receive WebMD's popular Diabetes newsletter.

webMD Video

Show or hide information about video: Vinegar for Diabetes   Vinegar for Diabetes

48x48_vinegar_for_diabetes.jpg

Vinegar is in everything from coleslaw to pickles. What if you could actually use it to help prevent disease?

Watch Video: Vinegar for Diabetes (opens in a new window)

Show or hide information about video: Pre-Diabetes   Pre-Diabetes

Show or hide information about video: Type 2 Diabetes in Kids   Type 2 Diabetes in Kids

Show or hide information about video: Continuous Glucose Monitors   Continuous Glucose Monitors

Show or hide information about video: Snacks for Diabetics   Snacks for Diabetics

Advertise on Fox News Channel, FOXNews.com and FOX News Radio Jobs at FOX News Channel. Internships at FOX News Channel (now accepting Fall interns).
Terms of use. Privacy Statement. For FOXNews.com comments write to foxnewsonline@foxnews.com; For FOX News Channel comments write to comments@foxnews.com
© Associated Press. All rights reserved.
SMARTMONEY ® © 2006 SmartMoney. SmartMoney is a joint publishing venture of Dow Jones & Company, Inc. and Hearst SM Partnership. All Rights Reserved.
All quotes delayed by 20 minutes. Delayed quotes provided by ComStock.
Historical prices and fundamental data provided by Hemscott, Inc.
Mutual fund data provided by Lipper. Mutual Fund NAVs are as of previous day's close.
Earnings estimates provided by Zacks Investment Research.
Upgrades and downgrades provided by Briefing.com.
This material may not be published, broadcast, rewritten, or redistributed. © 2006 FOX News Network, LLC. All rights reserved. All market data delayed 20 minutes.